Paper39404356
The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species.
Nysten J and 5 others. mBio, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species. Papers, record 39404356. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39404356
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The riboflavin biosynthetic pathway as a novel target for antifungal drugs against Candida species.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Riboflavin | Major topic |
| Antifungal Agents | Major topic |
| Biosynthetic Pathways | Major topic |
| Candidiasis | Major topic |
| Candida glabrata | Major topic |
| Candida albicans | Major topic |
| Saccharomyces cerevisiae | Major topic |
| Animals | |
| Mice | |
| Disease Models, Animal | |
| Virulence | |
| Fungal Proteins |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 1S18121N | Fonds Wetenschappelijk Onderzoek (FWO) | PubMed | ||
| 1S19219N | Fonds Wetenschappelijk Onderzoek (FWO) | PubMed | ||
| 11PRR24N | Fonds Wetenschappelijk Onderzoek (FWO) | PubMed | ||
| C14/22/075 | Onderzoeksraad, KU Leuven (Research Council, KU Leuven) | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17401334 | High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method. | Nat Protoc | 2007 | https://conductscience.org/library/papers/17401334 | PubMed |
| 2 | 8349105 | Isogenic strain construction and gene mapping in Candida albicans. | Genetics | 1993 | https://conductscience.org/library/papers/8349105 | PubMed |
| 3 | 27435998 | Therapeutic activity of a Saccharomyces cerevisiae-based probiotic and inactivated whole yeast on vaginal candidiasis. | Virulence | 2017 | https://conductscience.org/library/papers/27435998 | PubMed |
| 4 | 27763259 | Antifungal Drugs: The Current Armamentarium and Development of New Agents. | Microbiol Spectr | 2016 | https://conductscience.org/library/papers/27763259 | PubMed |
| 5 | 33304888 | Production of Vitamin B2 (Riboflavin) by Microorganisms: An Overview. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/33304888 | PubMed |
| 6 | 30987351 | The Hidden Cost of Modern Medical Interventions: How Medical Advances Have Shaped the Prevalence of Human Fungal Disease. | Pathogens | 2019 | https://conductscience.org/library/papers/30987351 | PubMed |
| 7 | 23738751 | Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs. | Expert Opin Drug Discov | 2013 | https://conductscience.org/library/papers/23738751 | PubMed |
| 8 | 18671734 | 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate synthases of fungi and archaea. | FEBS J | 2008 | https://conductscience.org/library/papers/18671734 | PubMed |
| 9 | 38224705 | Global incidence and mortality of severe fungal disease. | Lancet Infect Dis | 2024 | https://conductscience.org/library/papers/38224705 | PubMed |
| 10 | 25404942 | Non-albicans Candida Infection: An Emerging Threat. | Interdiscip Perspect Infect Dis | 2014 | https://conductscience.org/library/papers/25404942 | PubMed |
| 11 | 16169922 | The Yeast Gene Order Browser: combining curated homology and syntenic context reveals gene fate in polyploid species. | Genome Res | 2005 | https://conductscience.org/library/papers/16169922 | PubMed |
| 12 | 22278842 | Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. | J Clin Microbiol | 2012 | https://conductscience.org/library/papers/22278842 | PubMed |
| 13 | 25979690 | Tipping the balance both ways: drug resistance and virulence in Candida glabrata. | FEMS Yeast Res | 2015 | https://conductscience.org/library/papers/25979690 | PubMed |
| 14 | 14597141 | Current perspectives on the cellular uptake and trafficking of riboflavin. | Adv Drug Deliv Rev | 2003 | https://conductscience.org/library/papers/14597141 | PubMed |
| 15 | 23500531 | The human flavoproteome. | Arch Biochem Biophys | 2013 | https://conductscience.org/library/papers/23500531 | PubMed |
| 16 | 32054466 | Production of riboflavin and related cofactors by biotechnological processes. | Microb Cell Fact | 2020 | https://conductscience.org/library/papers/32054466 | PubMed |
| 17 | 21646432 | Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. | Microbiol Mol Biol Rev | 2011 | https://conductscience.org/library/papers/21646432 | PubMed |
| 18 | 38832801 | Candida albicans and Candida glabrata: global priority pathogens. | Microbiol Mol Biol Rev | 2024 | https://conductscience.org/library/papers/38832801 | PubMed |
| 19 | 14007303 | Regulation of flavin synthesis by Escherichia coli. | J Gen Microbiol | 1962 | https://conductscience.org/library/papers/14007303 | PubMed |
| 20 | 32548176 | Fungal infections in humans: the silent crisis. | Microb Cell | 2020 | https://conductscience.org/library/papers/32548176 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42875449 | Compound Z247611722 Exhibits Antifungal Activity by Inhibiting Serine Palmitoyltransferase. | Nat Commun | 2026 | https://conductscience.org/library/papers/42875449 | PubMed |
| 41968200 | High throughput screen reveals four compounds with novel antifungal activity, including a metal-responsive candidate with in vivo efficacy against Candida albicans. | Sci Rep | 2026 | https://conductscience.org/library/papers/41968200 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39404356
GET https://conductscience.org/api/papers/v1/39404356/references?page=2